Key result
Elevated intraplatelet ROS and platelet damage post-CF-LVAD are linked to non-surgical bleeding.
Why the study?
Non-surgical bleeding is the most common complication in heart failure patients supported by continuous-flow LVADs, and the role of platelet functionality in this bleeding is not well understood.
Do intraplatelet reactive oxygen species and platelet damage associate with non-surgical bleeding in heart failure patients supported by CF-LVAD?
Observational (n=36)
Do intraplatelet reactive oxygen species and platelet damage associate with non-surgical bleeding in heart failure patients supported by CF-LVAD?
Elevated intraplatelet reactive oxygen species and platelet damage are associated with non-surgical bleeding in heart failure patients with CF-LVADs, providing mechanistic insights into this common complication.
Answers are grounded in this paper and cite their sources.
Should not yet change CF-LVAD management; hypothesis-generating for ROS-targeted interventions to reduce bleeding.
Non-surgical bleeding (NSB) is the most common clinical complication among heart failure (HF) patients supported by continuous-flow left ventricular assist devices (CF-LVADs). Understanding the role of platelet functionality contributing to NSB after CF-LVAD implantation is crucial for prevention and management of this adverse event. The aim of this study was to examine the role of intraplatelet reactive oxygen species (ROS) and platelet damage on the incidence of bleeding events after CF-LVAD implantation in HF patients. We recruited 25 HF patients implanted with CF-LVADs and 11 healthy volunteers as the control. Intraplatelet ROS generation, platelet mitochondrial damage and platelet apoptosis were quantified by flow cytometry. Among 25 patients, 8 patients developed non-surgical bleeding within one month after CF-LVAD implantation. Intraplatelet ROS, depolarized and apoptotic platelet were found to be pre-existing conditions in all baseline samples of the 25 HF patients when compared to the healthy volunteers. There was no significant difference in the levels of ROS between the non-bleeder and the bleeder groups prior to CF-LVAD implantation, although we noticed 2-fold and 1.5-fold rise in depolarized and apoptotic platelets, respectively, in the bleeder group compared to those in the non-bleeder group. Post implant levels of intraplatelet ROS, depolarized and apoptotic platelets increased and remained elevated in the bleeder group, whereas periodic decreases were noticed in the non-bleeder group, suggesting the potential role of platelet damage on bleeding incidence. ROS generation after CF-LVAD implantation positively associated with platelet apoptosis (ρ = 0.4263, p = 0.0023) and depolarized platelets (ρ = 0.4774, p = 0.0002), especially the latter. In conclusion, elevated intraplatelet ROS and platelet damage may be linked to the NSB among HF patients supported by CF-LVAD. These results provide mechanistic insights into the bleeding complication in patients with CF-LVAD support.
No takes yet. Share an insight, caveat, or question.
Mondal et al. (2014) conducted an observational in Heart failure supported by continuous-flow left ventricular assist device (n=36). Intraplatelet reactive oxygen species and platelet damage vs. Healthy volunteers and non-bleeding CF-LVAD patients was evaluated on Non-surgical bleeding within one month after CF-LVAD implantation. Elevated intraplatelet reactive oxygen species and platelet damage post-CF-LVAD implantation were associated with non-surgical bleeding, with ROS positively correlating with depolarized platelets.
Synapse has enriched 10 related papers. Consider them for comparative context: